High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
Cherqui
D
D
Liver Transplant Unit, Hôpital Henri Mondor-Université Paris XII, Créteil, France.
Duvoux
C
C
Salvat
A
A
Lauzet
J Y
JY
Metreau
J M
JM
Julien
M
M
Fagniez
P L
PL
Dhumeaux
D
D
D000208:Acute Disease; D001379:Azathioprine / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001707:Biopsy, Needle; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000502:physiology; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011446:Prospective Studies; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors
D016853:Muromonab-CD3; D013256:Steroids; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D001663:Bilirubin; D008775:Methylprednisolone